Scolaris Content Display Scolaris Content Display

El efecto de la vitamina B6 sobre la cognición

Contraer todo Desplegar todo

Referencias

Referencias de los estudios incluidos en esta revisión

Bryan 2002 {published data only}

Bryan J, Calvaresi E, Hughes D. Short term folate vitamin B12 or vitamin B6 supplementation slightly affects memory performance but not mood in women of various ages. Journal of Nutrition 2002;132(6):1345‐56.

Deijen 1992 {published data only}

Deijen JB, Van der Beek EJ, Orlebeke JF, Van den Berg H. Vitamin B6 supplementation in elderly men effects on mood memory performance and mental effort. Psychopharmacology 1992;109(4):489‐96.

Referencias de los estudios excluidos de esta revisión

Balk 2007 {published data only}

Balk EM, Raman G, Tatsioni A, Chung M, Lau J, Rosenberg IH. Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials. Archive of Internal Medicine 2007;167(1):21‐30.

Carney 1976 {published data only}

Carney MW, Cashman MD, King A, Rogan PA, Sheffield BF. Severly demented patients beyond help of drugs. Modern Geriatrics 1976;6(10):36‐9.

Chandra 2001 {published data only}

Chandra PK. Effect of vitamin and trace element supplementation on cognitive function in elderly subjects. Nutrition 2001;17(9):709‐12.

Clarke 2007 {published data only}

Clarke R. Homocysteine‐lowering vitamin B supplements do not improve cognitive performance in healthy older adults after two years. Evidence‐Based Mental Health 2007;10(1):27.

Cockle 2000 {published data only}

Cockle SM, Haller J, Kimber S, Dawe RA, Hindmarch I. The influence of multivitamins on cognitive function and mood in the elderly. Aging and Mental Health 2000;4(4):339‐53.

Flicker 2007 {published data only}

Flicker L, Martins RN, Thomas J, Acres J, Taddei K, Vasikaran SD, et al. B‐vitamins reduce plasma levels of beta amyloid. Neurobiology of Aging 2008;29(2):303‐5.

McMahon 2006 {published data only}

McMahon JA, Green TJ, Skeaff CM, Knight RG, Mann JI, Williams SM. A controlled trial of homocysteine lowering and cognitive performance. New England Journal of Medicine 2006;354(26):2764‐72.

Schroecksandel 2006 {published data only}

Schroecksnadel K, Gruber B, Frick B, Jenny M, Ledochowski M, Leblhuber F, et al. Long‐term supplementation with B vitamins does not change plasma neopterin concentrations in demented patients. Pteridines 2006;17(4):135‐44.

Stott 2006 {published data only}

Stott DJ, MacIntosh G, Lowe GD, Rumley A, McMahon AD, Langhorne P, et al. Randomized controlled trial of homocysteine‐lowering vitamin treatment in elderly patients with vascular disease. The American Journal of Clinical Nutrition 2005;82(6):1320‐6.

Sun 2007 {published data only}

Sun Y, Lu CJ, Chien KL, Chen ST, Chen RC. Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26‐week, randomized, double‐blind, placebo‐controlled study in Taiwanese patients. Clinical Therapeutic 2007;29(10):2204‐14.

Van Uffelen 2007 {published data only}

van Uffelen JG, Chin A, Paw MJ, Hopman‐Rock M, van Mechelen W. The effect of walking and vitamin B supplementation on quality of life in community‐dwelling adults with mild cognitive impairment: a randomized, controlled trial. Quality of Life Research 2007;16(7):1137‐46.

Wouters 2002 {published data only}

Wouters‐Wesseling W, Wouters AEJ, Kleijer CN, Bindels JG, de Groot CPGM, Van Staveren WA. study of the effect of a liquid nutrition supplement on the nutritional status of psychogeriatric nursing home patients. European Journal of Clinical Nutrition 2002;56(3):245‐51.

APA 1987

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd Edition. Washington: APA, 1987.

Baddeley 1988

Baddeley A, Emslie H, Nimmo‐Smith I. Estimating permorbid intelligence. Journal of Clinical Experimental Neuropsychology 1988;10:326.

Bates 1999

Bates CJ, Pentieva KD, Prentice A, Mansoor MA, Finch S. Plasma pyridoxal phosphate and pyridoxic acid and their relationship to plasma homocysteine in a representative sample of British men and women aged 65 years and over. British Journal of Nutrition 1999;81:191‐201.

Beatty 1977

Beatty J, Wagoner BL. Pupillometric signs of brain activation vary with level of cognitive processing. Science 1977;199:1216‐18.

Benton 1989

Benton AL, Hamsher D. Multilingual Aphasia Examination. Iowa City, IA: University of Iowa, 1989.

Blumberg 1944

Blumberg J. Nutrient requirement of the healthy elderly: should there be specific RDAs?. Nutrition Reviews 1944;52:S15‐18.

Bostom 1999

Bostom Ag, Silbershatz H, Rosenberg IH. Nonfasting plasma total homocysteine levels and all cause and cardiovascular disease mortality in elderly Framingham men and women. Archives of Internal Medicine 1999;159:1077‐80.

Bots 1997

Bots Ml, Launer LJ, Lindemans J, Hofman A, Grobbee DE. Homocysteine atherosclerosis and prevalent cardiovascular disease in the elderly the Rotterdam Study. Journal of Internal Medicine 1997;242:339‐47.

Bryan 1997

Bryan J, Luzcz MA, Crawford JR. Verbal knowledge and speed of information processing as mediators of age differences in verbal fluency performance among older adults. Journal of Psychology of Aging 1997;12:473‐78.

Bryan 2001

Bryan J, Luszcz MA. Adult age difference in self ordered pointing task performance contributions from working memory executive function and speed of information processing. Journal of Clinical and Experimental Neuropsychology 2001;23:608‐19.

Callahan 1995

Callahan CM, Hendrie HC, Tierney WM. Documentation and evaluation of cognitive impairment in elderly primary care patients. Annals of Internal Medicine 1995;122:422‐29.

Carr 1997

Carr DB, Goate A, Phil D, Morris JC. Current concepts in the pathogenesis of Alzheimer's disease. American Journal of Medicine 1997;103:3S‐10S.

Chalmers 1983

Chalmers TC, Celano P, Sacks HS, Smith H, Junior. Bias in Treatment Assignment in Controlled Clinical Trials. New England Journal of Medicine 1983;309:1358‐61.

Chen 1981

Chen LH, Fan ‐Chiang WL. Biochemical evaluation of riboflavin and vitamin B6 status of institutionalised and non‐institutionalised elderly in Central Kentucky. International Journal of Vitamin and Nutrition Research 1981;51:232‐3.

Clarke 1998

Clarke R, Smith Ad, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate vitamin B12 and serum total homocysteine levels in confirmed Alzheimer's disease. Archives of Neurology 1998;55:1449‐55.

Deijen 1992

Deijen JB, Van Der Berk EJ, Orlebeke JF, Van Den Berg H. Vitamin B6 supplementation in elderly men: effects on mood memory performance and mental effort. Psychopharmacology 1992;109:489‐96.

Dodrill 1978

Dodrill J, Luszcz MA. A neuropsychological battery for epilepsy. Epilepsia 1978;19:611‐23.

Dyer 1973

Dyer FN. The Stroop phenomenon and its use in the study of perceptual cognitive and response processes. Memory and Cognition 1973;1:106‐20.

Earles 1995

Earles JL, Salthouse TA. Interrelations of age health and speed. Journals of Gerontology B Psychological and Social Science 1995;50B:33‐41.

Emmen 1988

Emmen HH, Hogendijk EMG, Hooisma J, Orlebeke JF, Uitdehaage SHJ. Adaptation of two standardized international test batteries for use in the Netherlands for detection of exposure to neurotoxic compounds. Internal Report. Rijswijk:Medisch Biologisch Laboratorium TNO1988.

Evans 2002

Evans WC, Evans D. Trease and Evans Pharmacology. Fifteenth Edition. Edinburgh, London, New York, Philadelphia, St Louis, Sydney, Toronto: W.B. Saunders, 2002.

Fabbender 1999

Fabbender K, Mielke O, Bertsch T, Bernhard N, Stefanie F, Hennerici M. Homocysteine in cerebral macroangiography and microangiopathy. The Lancet 1999;353:1586‐7.

Getzels 1962

Getzels JW, Jackson PW. Creativity and Intelligence. New York: Wiley, 1962.

Goodwin 1983

Goodwin JS, Goodwin JM, Garry PJ. Association between nutritional status and cognitive functioning in a healthy elderly population. Journal of the American Medical Association 1983;249:2917‐21.

Janke 1978

Janke W, Debus G. List of adjectives/The PC/S Vienna Test System. Modling, Austria: Dr. G. Schuhfried, 1978.

Jensen 1966

Jensen AR, Rohwer WD. The stroop color word test: a review. Acta Psychologica 1966;25:36‐93.

Joosten 1993

Joosten E, Van den Berg A, Riezler R, Naurath HJ, Lindenbaum J, Stabler SP, et al. Metabolic evidence that deficiencies of vitamin B12 cobalamin, folate and vitamin B6 occur commonly in elderly people. American Journal of Clinical Nutrition 1993;58:468‐76.

Kahneman 1967

Kahneman D, Beatty J. Pupillary responses in a pitch‐discrimination task. Perception and Psychophysics 1967;2:101‐5.

Kant 1988

Kant AK, Moser‐Veillon PB, Reynolds RD. Effect of age on changes in plasma erythrocyte and urinary B6 vitamin after an oral vitamin B6 load. American Journal of Clinical Nutrition 1988;48:1284‐90.

Karnovsky 1974

Karnovsky AR. Sex differences in spatial ability a development study. Dissertation Abstracts International 1974;34:813.

Klemenjak 1983

Klemenjak W. [Neue Methoden der apparativen Erfassung kognitieven leistungen]. Kuratorium fur Verkehrssicherheit. Das Wiener Konzentrationgerat (Congitrone), 1983.

Knopman 1998

Knopman. The initial recognition and diagnosis of dementia. American Journal of Medicine 1998;104(4A):S2‐S12.

La Rue 1997

La Rue A, Koehler KM, Wayne SJ, Chiulli SJ, Haaland KY, Garry PJ. Nutritional status and cognitive functioning in a normally aging sample: a 6 years reassessment. American Journal of Clinical Nutrition 1997;65:20‐9.

Lezak 1995

Lezak MD. Neuropsychological assessment. 3rd Edition. Oxford, New York: Oxford University Press, 1995.

Lowik 1989

Lowik MRH, Van den Berg H, Westenbrink S, Wedel M, Schrijver J, Ockhuizen T. Dose response relationships regarding vitamin B6 ib elderly people a nationwide nutrition survey Dutch Nutritional Surveillance System. American Journal of Clinical Nutrition 1989;50:391‐99.

Lowik 1992

Lowik MRH, Van Den Berg H, Schrijver J, Odink J, Wedel M, Van Houten. Marginal nutritional status among institutional elderly women as compared to those living more independently. Dutch Nutrition Surveillance System. Journal of the American College of Nutrition 1992;11:673‐81.

Majeres 1988

Majeres RL. Serial comparison processes and sex difference in clerical speed. Intelligence 1988;14:149‐65.

Majeres 1990

Majeres RL. Sex difference in comparison and decision processes when matching strings of symbols. Intelligence 1990;14:375‐70.

Malec 1992

Malec JF, Ivnik RJ, Smith GE. Mayo's older American normative studies utility of corrections for age and education for the WAIS‐R. The Clinical Neuropsychologist 1992;suppl. 6:31‐47.

McCddon 1998

McCddon A, Davis G, Hudson P, Tandy S, Cattell H. Total serum homocysteine in senile dementia of Alzheimer type. International Journal of Geriatrric Psychiatry 1998;13:235‐9.

McCormick 2001

McCormick DB. Vitamin B6. 8th Edition. Washington DC: ILSI Press, 2001. [PP 207‐13]

McKhann 1984

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease report of the NINCDS‐ADRDA work group under the auspices of department of health and human services task force on Alzheimer’s disease. Neurology 1984;4:933‐44.

McNair 1971

McNair PM, Lorr M, Droppelmen LF. Profile of mood states manual. San Diego, CA: Education and industrial testing service, 1971.

Miller 1999

Miller JW. Homocysteine and Alzheimer's disease. Nutrition Reviews 1999;57:126‐9.

Miller 2002

Miller JW, Green R, Mungas DM, Reed BR, Jagust WJ. Homocysteine vitamin B6 and vascular disease in AD patients. Neurology 2002;58:1471‐75.

Molimard 1980

Mulimard R, Marillaud A, Paille A, LeDevehat C, Lemoine A, et al. IMpairment of memorization by high doses of pyridoxine in man. Biomedicine 1980;32:88‐92.

Mulrow 1997

Mulrow CD, Oxman AD (editors). Cochrane Collaboration Handbook. The Cochrane Collaboration, issue 1, updated quarterly. Oxford: update software, 1997.

Pannemans 1994

Pannemans DLE, Van den Berg H, Westerterp KP. The influence of protein intake on vitamin B6 metabolism differs in young and elderly humans. Journal of Nutrition 1994;124:1207‐14.

Petrides 1982

Petrides M, Milner B. Deficits on subject ordered tasks after frontal and temporal lobe lesions in man. Neuropsychologia 1982;20:249‐62.

Radloff 1977

Radloff LS. The CES‐D scale a self report depression scale for research in the general population. Applied Psychological Measurement 1977;1:385‐401.

Reitan 1985

Reitan RM, Wolfson D. The Halstead Reitan Neuropsychological Test Battery. Tucson, AZ: Neuropsychology Press, 1985.

Rey 1964

Rey A. L'examen Clinique en Psychologie. Paris: Press Universitaires de France, 1964.

Riggs 1996

Riggs KM, Spiro A, Rush D. Relations of vitamin B12, vitamin B6, folate and homocysteine to cognitive performance in the Normative Aging Study. American Journal of Clinical Nutrition 1996;63:306‐14.

Rose 1976

Rose CS, Gyorgy P, Butler M, Anders R, Norris AH, Shock NW, Tobin J, Brin M, Spiegel H. Age difference in vitamin B6 status of 617 men. American Journal of Clinical Nutrition 1976;29:847‐53.

Rowland 2000

Rowland LP. Merritt's Neurology. 10th Edition. Philadelphia: Lippincott Wiliams and Wilkins, 2000.

Schneider 1990

Schneider EP. The aging of America: impact on health care costs. Journal of the American Medical Association 1990;263:2335‐40.

Schulz 1995

Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association 1995;273:408‐12.

Selhub 1993

Selhub J, Jacques PF, Wilson OWF, Rush D, Rosenberg IH. Vitamin status and intakes as primary determinants of homocysteine in an elderly population. Journal of the American Medical Association 1993;270:2693‐8.

Selhub 1995

Selhub J, Jacques PF, Bostom AG. Association between plasma homocysteine concentrations and extracranial carotid artery stenosis. New England Journal of Medicine 1995;322:286‐91.

Sperling 1960

Sperling G. The information available in brief visual presentations. Psychological Monographs 1960;74:1‐29.

Talbott 1987

Talbott MC, Miller LT, Kerkvliet NI. Pyridoxine supplementation effect on lymphocyte responses in elderly persons. American Journal of Clinical Nutrition 1987;46(4):659‐64.

Tolonen 1988

Tolonen M, Schrijver J, Westermarck T, Halme M, Touminen SEJ, et al. Vitamin B6 status of Finnish elderly comparison with Dutch younger adults and elderly the effect of supplementation. International Journal of Vitamin and Nutrition Research 1988;58:73‐77.

Walmusley 1999

Walmusley CM, bates CJ, Prentice A, Cole TJ. Relationship between alcohol and nutrient intakes and blood status indices of older people living in the UK: further analysis of data from the national diet and nutrition survey of people aged 65 years and over. Public Health Nutrition 1999;1:157‐67.

Wechsler 1955

Wechsler D. WAIS manual. New York: The Psychological Corporation, 1955.

Wechsler 1981

Wechsler D. WAIS‐R manual. New York: The Psychological Corporation, 1981.

Wechsler 1997

Wechsler D. Wechsler Adult Intelligence Scale. 3rd Edition. Harcourt Brace, San Antonio, TX: The psychological corporation, 1997.

White 1996

White L, Petrovitch H, Ross GW. Prevalence of dementia in older Japanese‐American men in Hawaii. Journal of the American Medical Association 1996;276:955‐960.

Referencias de otras versiones publicadas de esta revisión

Malouf 2003

Malouf R, Grimley Evans J. Vitamin B6 for cognition. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD004393]

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Bryan 2002

Methods

A 35 days randomized, double‐blind, placebo‐controlled study, a mixed factorial design was used

Participants

Country: Australia
211 participants were divided into three groups;
*56 in younger aged group (20 and 30 y)
*80 in middle aged group (45 and 55y)

*75 in older aged group (65‐92 y):
1) 21 received placebo
2)12 received vitamin B6

Selection criteria:
*Non‐smokers
*Not on HRT
*Not using any medication that affects mental performance or mood
*Not used vitamin supplementation within 2 weeks before start of the study
*English as first language or proficiency in English

Interventions

1. placebo
2. folate 750 mcg
3. vitamin B12 15 mcg
4. vitamin B6 75 mg

Outcomes

A) Cognitive measures:
1‐Speed of processing using the following batteries of tests:
*Boxes test
*Digit‐Symbol Coding
*Symbol Search
2‐Working memory
*Digit Span‐Backward
*Letter‐Number Sequencing
3‐Memory Measures:
*Free recall:
i‐Immediate Recall
ii‐Delayed Recall
iii‐Recognition
4‐Incidental Recall:
*Digit Symbol
*Symbol position
*Activities
5‐Executive function:
*Stroop
*Self‐Ordered Pointing Task
*Trial Making Test
*Verbal Fluency:
i‐Initial Letter
ii‐Excluded Letter
6‐Verbal Ability:
*Vocabulary
*Spot the word

B) Mood Measures
1‐CESD
2‐Tension/anxiety
3‐Depression/dejection
4‐Anger/hostility
5‐Vigour/activity
6‐Fatigue/inertia
7‐Confusion/bewilderment

Notes

One participant dropped out from the folic acid group

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Low risk

A ‐ Adequate

Deijen 1992

Methods

A 12 week randomized, double‐blind, placebo‐controlled trial

Participants

Country: The Netherlands
76 men were divided into two pair‐matched groups, placebo and vitamin B6 groups.

Entry criteria:
1) Healthy men
2) Aged between 70 and 79
3) Restricted alcohol use, a maximum of four glasses a day
4) Intelligence score above 80

Exclusion criteria:
1) On any medication affecting vitamin B6 metabolism
2) Use of vitamin B6 supplements within 3 months before the trial
3) Suffering from auto‐immune disease

Interventions

1) Placebo
2) Vitamin B6 20 mg/day for 12 weeks

Outcomes

A) Vitamin B6 status:
1‐PLP
2‐Alpha‐EAST

B) Mood using the list of adjective
C) Memory:
1‐Immediate memory
2‐Short‐Term Verbal Memory
3‐Long‐Term Verbal Memory using the associated recognition task
4‐Long‐term memory storage
5‐Long‐term visual memory
6‐Attention and performance
7‐Perceptual‐motor skill
D) Pupil size:
A) Short term memory task
B) Speed of processing task

Notes

The pairs were matching in age, vitamin B6 status and IQ

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Low risk

A ‐ Adequate

HRT: Hormone Replacement Therapy
CESD: The Center for Epidemiological Studies Depression Scale
POMS: The Profile of Mood States Questionnaire
PLP: Plasma Pyridoxal‐5'‐Phosphate
Alpha‐EAST: Erythrocyte Aspartate Aminotransferase
IQ: Intelligence Quotient

Characteristics of excluded studies [ordered by year of study]

Study

Reason for exclusion

Cockle 2000

RCT of multi‐vitamins

Stott 2006

RCT, using folic acid plus vitamin B12, vitamin B6, vitamin B2 and placebo in patients with vascular disease. Patients with MCI and dementia were excluded

Schroecksandel 2006

Not RCT, B vitamin supplementation in Alzheimer's disease, vascular dementia, mild cognitive impairment patients

Chandra 2001

Interventional study of multi‐vitamins and elements

Carney 1976

The intervention included the combination of the following vitamins: B1, B6, B12 and C

Wouters 2002

RCT of micronutrient‐enriched liquid

McMahon 2006

RCT, Comparing B vitamins (B6, B12, folic acid) with placebo in elderly healthy people

Van Uffelen 2007

RCT, Comparing B vitamin (B6, B12, folic acid) plus a walking programme with placebo in mild cognitive impairment patients

Flicker 2007

RCT, comparing B vitamins (B6, B12, folic acid) with placebo in older men

Balk 2007

A review of the effect of B vitamins (B6, B12 , folic acid) on cognitive function

Clarke 2007

RCT, comparing B vitamins (B6,B12, folic acid) to placebo

Sun 2007

RCT comparing B6, B12 and folic acid with placebo in demented persons

MCI: Mild Cognitive Impairment

Data and analyses

Open in table viewer
Comparison 1. 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Speed of processing Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

Analysis 1.1

Comparison 1 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women, Outcome 1 Speed of processing.

Comparison 1 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women, Outcome 1 Speed of processing.

1.1 Boxes Test

1

33

Mean Difference (IV, Fixed, 95% CI)

1.57 [‐14.08, 17.22]

1.2 Digit‐Symbol Coding

1

33

Mean Difference (IV, Fixed, 95% CI)

3.89 [‐10.69, 18.47]

1.3 Symbol Search

1

33

Mean Difference (IV, Fixed, 95% CI)

0.06 [‐3.61, 3.73]

2 Working Memory Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

Analysis 1.2

Comparison 1 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women, Outcome 2 Working Memory.

Comparison 1 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women, Outcome 2 Working Memory.

2.1 Digit Span‐Backwards

1

33

Mean Difference (IV, Fixed, 95% CI)

‐0.48 [‐2.73, 1.77]

2.2 Letter‐Number Sequencing

1

33

Mean Difference (IV, Fixed, 95% CI)

‐0.55 [‐3.45, 2.35]

3 Free Recall Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

Analysis 1.3

Comparison 1 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women, Outcome 3 Free Recall.

Comparison 1 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women, Outcome 3 Free Recall.

3.1 Immediate Recall: RAVLT 1‐5

1

33

Mean Difference (IV, Fixed, 95% CI)

‐2.21 [‐11.40, 6.98]

3.2 Immediate Recall: RAVLT B

1

33

Mean Difference (IV, Fixed, 95% CI)

1.07 [‐0.63, 2.77]

3.3 Delayed Recall: RAVLT 6

1

33

Mean Difference (IV, Fixed, 95% CI)

‐0.32 [‐3.49, 2.85]

3.4 Delayed Recall: RAVLT 7

1

33

Mean Difference (IV, Fixed, 95% CI)

0.67 [‐212.77, 214.11]

3.5 Recognition: RAVLT A

1

33

Mean Difference (IV, Fixed, 95% CI)

0.28 [‐2.61, 3.17]

3.6 Recogntion ‐RAVLT B

1

33

Mean Difference (IV, Fixed, 95% CI)

1.23 [‐2.15, 4.61]

4 Executive Function Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

Analysis 1.4

Comparison 1 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women, Outcome 4 Executive Function.

Comparison 1 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women, Outcome 4 Executive Function.

4.1 Stroop Test

1

33

Mean Difference (IV, Fixed, 95% CI)

‐0.06 [‐0.50, 0.38]

4.2 Uses of Objects

1

33

Mean Difference (IV, Fixed, 95% CI)

1.16 [‐3.92, 6.24]

4.3 Trail Making Test A

1

33

Mean Difference (IV, Fixed, 95% CI)

‐12.73 [‐29.05, 3.59]

4.4 Trail Making Test B

1

33

Mean Difference (IV, Fixed, 95% CI)

‐6.05 [‐46.55, 34.45]

4.5 Verbal Fluency ‐Initial Letter

1

33

Mean Difference (IV, Fixed, 95% CI)

‐2.08 [‐8.00, 5.84]

4.6 Verbal Fluency Excluded Letter

1

33

Mean Difference (IV, Fixed, 95% CI)

6.57 [‐2.97, 16.11]

5 Verbal Ability Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

Analysis 1.5

Comparison 1 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women, Outcome 5 Verbal Ability.

Comparison 1 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women, Outcome 5 Verbal Ability.

5.1 Vocabulary

1

33

Mean Difference (IV, Fixed, 95% CI)

0.74 [‐6.02, 7.50]

5.2 Spot the Word

1

33

Mean Difference (IV, Fixed, 95% CI)

‐1.65 [‐14.14, 10.84]

6 Mood Measures Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

Analysis 1.6

Comparison 1 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women, Outcome 6 Mood Measures.

Comparison 1 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women, Outcome 6 Mood Measures.

6.1 CESD

1

33

Mean Difference (IV, Fixed, 95% CI)

0.61 [‐4.78, 6.00]

6.2 POMS total

1

33

Mean Difference (IV, Fixed, 95% CI)

2.77 [‐12.28, 17.82]

6.3 Tension/Anxiety

1

33

Mean Difference (IV, Fixed, 95% CI)

0.20 [‐4.27, 4.67]

6.4 Depression/dejection

1

33

Mean Difference (IV, Fixed, 95% CI)

‐0.64 [‐4.78, 3.50]

6.5 Anger/hostility

1

33

Mean Difference (IV, Fixed, 95% CI)

‐1.28 [‐5.22, 2.66]

6.6 Vigour/Activity

1

33

Mean Difference (IV, Fixed, 95% CI)

‐2.35 [‐8.42, 3.72]

6.7 Fatigue/inertia

1

33

Mean Difference (IV, Fixed, 95% CI)

1.38 [‐2.16, 4.92]

6.8 Confusion/bewilderment

1

33

Mean Difference (IV, Fixed, 95% CI)

0.4 [‐1.90, 2.70]

Open in table viewer
Comparison 2. 20 mg vitamin B6/day for 12 weeks vs placebo in healthy older men

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 PLP Show forest plot

1

76

Mean Difference (IV, Fixed, 95% CI)

238.00 [211.58, 264.42]

Analysis 2.1

Comparison 2 20 mg vitamin B6/day for 12 weeks vs placebo in healthy older men, Outcome 1 PLP.

Comparison 2 20 mg vitamin B6/day for 12 weeks vs placebo in healthy older men, Outcome 1 PLP.

2 Alpha‐EAST Show forest plot

1

76

Mean Difference (IV, Fixed, 95% CI)

0.43 [0.30, 0.56]

Analysis 2.2

Comparison 2 20 mg vitamin B6/day for 12 weeks vs placebo in healthy older men, Outcome 2 Alpha‐EAST.

Comparison 2 20 mg vitamin B6/day for 12 weeks vs placebo in healthy older men, Outcome 2 Alpha‐EAST.

3 Associated Recognition Task Show forest plot

1

76

Mean Difference (IV, Fixed, 95% CI)

‐1.02 [‐2.40, 0.36]

Analysis 2.3

Comparison 2 20 mg vitamin B6/day for 12 weeks vs placebo in healthy older men, Outcome 3 Associated Recognition Task.

Comparison 2 20 mg vitamin B6/day for 12 weeks vs placebo in healthy older men, Outcome 3 Associated Recognition Task.

4 Forget Scores Show forest plot

1

76

Mean Difference (IV, Fixed, 95% CI)

0.79 [‐0.34, 1.92]

Analysis 2.4

Comparison 2 20 mg vitamin B6/day for 12 weeks vs placebo in healthy older men, Outcome 4 Forget Scores.

Comparison 2 20 mg vitamin B6/day for 12 weeks vs placebo in healthy older men, Outcome 4 Forget Scores.

Comparison 1 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women, Outcome 1 Speed of processing.
Figuras y tablas -
Analysis 1.1

Comparison 1 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women, Outcome 1 Speed of processing.

Comparison 1 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women, Outcome 2 Working Memory.
Figuras y tablas -
Analysis 1.2

Comparison 1 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women, Outcome 2 Working Memory.

Comparison 1 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women, Outcome 3 Free Recall.
Figuras y tablas -
Analysis 1.3

Comparison 1 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women, Outcome 3 Free Recall.

Comparison 1 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women, Outcome 4 Executive Function.
Figuras y tablas -
Analysis 1.4

Comparison 1 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women, Outcome 4 Executive Function.

Comparison 1 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women, Outcome 5 Verbal Ability.
Figuras y tablas -
Analysis 1.5

Comparison 1 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women, Outcome 5 Verbal Ability.

Comparison 1 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women, Outcome 6 Mood Measures.
Figuras y tablas -
Analysis 1.6

Comparison 1 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women, Outcome 6 Mood Measures.

Comparison 2 20 mg vitamin B6/day for 12 weeks vs placebo in healthy older men, Outcome 1 PLP.
Figuras y tablas -
Analysis 2.1

Comparison 2 20 mg vitamin B6/day for 12 weeks vs placebo in healthy older men, Outcome 1 PLP.

Comparison 2 20 mg vitamin B6/day for 12 weeks vs placebo in healthy older men, Outcome 2 Alpha‐EAST.
Figuras y tablas -
Analysis 2.2

Comparison 2 20 mg vitamin B6/day for 12 weeks vs placebo in healthy older men, Outcome 2 Alpha‐EAST.

Comparison 2 20 mg vitamin B6/day for 12 weeks vs placebo in healthy older men, Outcome 3 Associated Recognition Task.
Figuras y tablas -
Analysis 2.3

Comparison 2 20 mg vitamin B6/day for 12 weeks vs placebo in healthy older men, Outcome 3 Associated Recognition Task.

Comparison 2 20 mg vitamin B6/day for 12 weeks vs placebo in healthy older men, Outcome 4 Forget Scores.
Figuras y tablas -
Analysis 2.4

Comparison 2 20 mg vitamin B6/day for 12 weeks vs placebo in healthy older men, Outcome 4 Forget Scores.

Comparison 1. 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Speed of processing Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

1.1 Boxes Test

1

33

Mean Difference (IV, Fixed, 95% CI)

1.57 [‐14.08, 17.22]

1.2 Digit‐Symbol Coding

1

33

Mean Difference (IV, Fixed, 95% CI)

3.89 [‐10.69, 18.47]

1.3 Symbol Search

1

33

Mean Difference (IV, Fixed, 95% CI)

0.06 [‐3.61, 3.73]

2 Working Memory Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

2.1 Digit Span‐Backwards

1

33

Mean Difference (IV, Fixed, 95% CI)

‐0.48 [‐2.73, 1.77]

2.2 Letter‐Number Sequencing

1

33

Mean Difference (IV, Fixed, 95% CI)

‐0.55 [‐3.45, 2.35]

3 Free Recall Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

3.1 Immediate Recall: RAVLT 1‐5

1

33

Mean Difference (IV, Fixed, 95% CI)

‐2.21 [‐11.40, 6.98]

3.2 Immediate Recall: RAVLT B

1

33

Mean Difference (IV, Fixed, 95% CI)

1.07 [‐0.63, 2.77]

3.3 Delayed Recall: RAVLT 6

1

33

Mean Difference (IV, Fixed, 95% CI)

‐0.32 [‐3.49, 2.85]

3.4 Delayed Recall: RAVLT 7

1

33

Mean Difference (IV, Fixed, 95% CI)

0.67 [‐212.77, 214.11]

3.5 Recognition: RAVLT A

1

33

Mean Difference (IV, Fixed, 95% CI)

0.28 [‐2.61, 3.17]

3.6 Recogntion ‐RAVLT B

1

33

Mean Difference (IV, Fixed, 95% CI)

1.23 [‐2.15, 4.61]

4 Executive Function Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

4.1 Stroop Test

1

33

Mean Difference (IV, Fixed, 95% CI)

‐0.06 [‐0.50, 0.38]

4.2 Uses of Objects

1

33

Mean Difference (IV, Fixed, 95% CI)

1.16 [‐3.92, 6.24]

4.3 Trail Making Test A

1

33

Mean Difference (IV, Fixed, 95% CI)

‐12.73 [‐29.05, 3.59]

4.4 Trail Making Test B

1

33

Mean Difference (IV, Fixed, 95% CI)

‐6.05 [‐46.55, 34.45]

4.5 Verbal Fluency ‐Initial Letter

1

33

Mean Difference (IV, Fixed, 95% CI)

‐2.08 [‐8.00, 5.84]

4.6 Verbal Fluency Excluded Letter

1

33

Mean Difference (IV, Fixed, 95% CI)

6.57 [‐2.97, 16.11]

5 Verbal Ability Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

5.1 Vocabulary

1

33

Mean Difference (IV, Fixed, 95% CI)

0.74 [‐6.02, 7.50]

5.2 Spot the Word

1

33

Mean Difference (IV, Fixed, 95% CI)

‐1.65 [‐14.14, 10.84]

6 Mood Measures Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

6.1 CESD

1

33

Mean Difference (IV, Fixed, 95% CI)

0.61 [‐4.78, 6.00]

6.2 POMS total

1

33

Mean Difference (IV, Fixed, 95% CI)

2.77 [‐12.28, 17.82]

6.3 Tension/Anxiety

1

33

Mean Difference (IV, Fixed, 95% CI)

0.20 [‐4.27, 4.67]

6.4 Depression/dejection

1

33

Mean Difference (IV, Fixed, 95% CI)

‐0.64 [‐4.78, 3.50]

6.5 Anger/hostility

1

33

Mean Difference (IV, Fixed, 95% CI)

‐1.28 [‐5.22, 2.66]

6.6 Vigour/Activity

1

33

Mean Difference (IV, Fixed, 95% CI)

‐2.35 [‐8.42, 3.72]

6.7 Fatigue/inertia

1

33

Mean Difference (IV, Fixed, 95% CI)

1.38 [‐2.16, 4.92]

6.8 Confusion/bewilderment

1

33

Mean Difference (IV, Fixed, 95% CI)

0.4 [‐1.90, 2.70]

Figuras y tablas -
Comparison 1. 75 mg Vitamin B6/day for five weeks vs placebo in healthy older women
Comparison 2. 20 mg vitamin B6/day for 12 weeks vs placebo in healthy older men

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 PLP Show forest plot

1

76

Mean Difference (IV, Fixed, 95% CI)

238.00 [211.58, 264.42]

2 Alpha‐EAST Show forest plot

1

76

Mean Difference (IV, Fixed, 95% CI)

0.43 [0.30, 0.56]

3 Associated Recognition Task Show forest plot

1

76

Mean Difference (IV, Fixed, 95% CI)

‐1.02 [‐2.40, 0.36]

4 Forget Scores Show forest plot

1

76

Mean Difference (IV, Fixed, 95% CI)

0.79 [‐0.34, 1.92]

Figuras y tablas -
Comparison 2. 20 mg vitamin B6/day for 12 weeks vs placebo in healthy older men